News: A concensus on the Rx for PCOS infertility

Article

Treatment of infertility in women with polycyctic ovary syndrome (PCOS).

Experts from around the globe met recently in Greece to develop a consensus regarding treatment of infertility in women with polycystic ovary syndrome (PCOS).

They agreed that before considering medical treatment, physicians should counsel patients on the importance of lifestyle changes including weight reduction, exercise, smoking, and alcohol consumption.

They also agreed that treatment should be tailored to each patient's individual circumstances, but that generally first-line treatment should consist of the anti-estrogen clomiphene citrate (CC) for ovulation induction. If this fails to result in pregnancy, second-line treatment should consist of either exogenous gonadotropins with intense monitoring of ovarian response because of the high chance for multiple pregnancy or laparoscopic ovarian surgery. Because the latter as a lone method is effective in fewer than 50% of women, additional ovulation induction medication is usually required. Treatment with CC and gonadotropins is associated with a cumulative singleton live-birth rate of 72%. Third-line treatment should consist of in vitro fertilization.

Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008;89:505-522.

Related Videos
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Exploring the intersection of heart health and women's health | Image Credit: cedars-sinai.org
Unlocking the benefits of DHEA | Image Credit: drannacabeca.com
Unlocking the power of oxytocin | Image credit: drannacabeca.com
Revolutionizing menopause management: A deep dive into fezolinetant | Image Credit: uvahealth.com.
© 2024 MJH Life Sciences

All rights reserved.